far more important to the valuation of the perpetual asset that is equity is the investment management of shareholder capital. ie. paying dividends (or buying back shares) where high ROE internal investments are not available. fortunately for csl it has plenty of high ROE internal projects to pour profits into thereby compounding high returns on shareholder funds. this aspect cannot be captured by a one point in time backward looking P/E ratio.
patience, while csl's internal investments begin to payoff, has been and will be rewarded.
UBS retained buy rate for CSL, page-37
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B | |||
| Open | High | Low | Value | Volume |
| $280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1140 | $277.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $277.08 | 312 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |